1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Massachusetts >
  6. Exits Lantheus Medical Imaging

Investment Summary

Exits Lantheus Medical Imaging

On December 17, 2017, invested in medical products company Lantheus Medical Imaging from Bristol-Myers Squibb for 525M USD

Investment Highlights
  • This is transaction in the Medical Products sector.
  • This is largest (disclosed) transaction.
  • This is transaction in the United States.
  • This is transaction in Massachusetts.

Investment Summary
Date 2017-12-17
Target Lantheus Medical Imaging
Sector Medical Products
Sellers(s) Bristol-Myers Squibb
Deal Type Divestiture
Deal Value 525M USD

Target

Lantheus Medical Imaging

North Billerica, Massachusetts, United States
Lantheus Medical Imaging is a supplier of radiopharmaceuticals and contrast agents for nuclear and ultrasound-based cardiovascular diagnostic imaging procedures. Lantheus Medical Imaging was founded in 1956 and is based in North Billerica, Massachusetts.

Search 205,173 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Bristol-Myers Squibb

Princeton, New Jersey, United States
Category Company
Founded 1887
Sector Life Science
Employees34,100
Revenue 45.0B USD (2023)
DESCRIPTION

Bristol-Myers Squibb is a life science company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. The Company's pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from biological processes. The majority of Bristol-Myers Squibb's revenue comes from products in the following therapeutic classes: cardiovascular; virology, including human immunodeficiency virus (HIV) infection; oncology; neuroscience; immunoscience; and metabolics. Bristol-Myers Squibb was incorporated in 1887 and is based in Princeton, New Jersey.

DEAL STATS #
Overall 9 of 13
Sector (Medical Products) 4 of 5
Type (Divestiture) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 8 of 8
Year (2017) 1 of 1
Size (of disclosed) 4 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-03 IFM Therapeutics

Boston, Massachusetts, United States

IFM Therapeutics is a biotech company focused on developing therapies that modulate novel targets in the innate immune system to treat cancer, autoimmunity and inflammatory disorders. IFM Therapeutics is based in Boston, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-08 Upsa

France

Upsa is a provider of an over-the-counter drugs business. Upsa is based in France.

Sell -
Mergr

Product

Company

Legal